CASTLE BIOSCIENCES, INC. Equity Securities, FV-NI, Gain (Loss)
CASTLE BIOSCIENCES, INC. (CSTL) reported Equity Securities, FV-NI, Gain (Loss) of -$630.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Income Statement › Other Income
us-gaap:EquitySecuritiesFvNiGainLoss · last filed 2026-07-30
- CASTLE BIOSCIENCES, INC. equity securities, fv-ni, gain (loss) for the quarter ending 2026-06-30 was -$630.00K, a 153.16% decline year-over-year.
- CASTLE BIOSCIENCES, INC. equity securities, fv-ni, gain (loss) for the quarter ending 2026-03-31 was $2.02M.
- CASTLE BIOSCIENCES, INC. equity securities, fv-ni, gain (loss) for the quarter ending 2025-06-30 was $1.19M.
- CASTLE BIOSCIENCES, INC. equity securities, fv-ni, gain (loss) for the quarter ending 2025-03-31 was -$1.43M.
- CASTLE BIOSCIENCES, INC. equity securities, fv-ni, gain (loss) for fiscal 2025 was $1.47M, a 164.14% increase from fiscal 2024.
- CASTLE BIOSCIENCES, INC. equity securities, fv-ni, gain (loss) for fiscal 2024 was $555.00K.
- CASTLE BIOSCIENCES, INC. equity securities, fv-ni, gain (loss) for fiscal 2023 was $0.00.
| Period end | Equity Securities, FV-NI, Gain (Loss) 3 month | Equity Securities, FV-NI, Gain (Loss) 6 month | Equity Securities, FV-NI, Gain (Loss) 12 month |
|---|---|---|---|
| 2026-06-30 | -$630.00K 10-Q · filed 2026-07-30 | $1.39M 10-Q · filed 2026-07-30 | |
| 2026-03-31 | $2.02M 10-Q · filed 2026-05-06 | ||
| 2025-12-31 | $1.47M 10-K · filed 2026-02-26 | ||
| 2025-06-30 | $1.19M 10-Q · filed 2026-07-30 | -$240.00K 10-Q · filed 2026-07-30 | |
| 2025-03-31 | -$1.43M 10-Q · filed 2026-05-06 | ||
| 2024-12-31 | $555.00K 10-K · filed 2026-02-26 | ||
| 2023-12-31 | $0.00 10-K · filed 2026-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B |